1 active not recruiting, 1 recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Sarcoma of Bone: new trials by email Literature Review of Sarcoma of Bone trials Research Report on Sarcoma of Bone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas CD146/HER2 CAR-T cells - Sarcoma, Sarcoma, Kaposi | Phase 1 / Phase 2 | Recruiting | Essen Biotech | 60 | 2025-05-29 | 2025-07-15 |
| In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors Anti-CD40 Agonist Monoclonal Antibody CDX-1140, Poly ICLC, Radiation Therapy - Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma | Phase 1 | Active not recruiting | University of Southern California | 14 | 2023-01-09 | 2026-06-18 |
Osteosarcoma (2) · Sarcoma (2) · Bone Neoplasms (1) · Breast Neoplasms (1) · Carcinoma, Basal Cell (1) · Carcinoma, Merkel Cell (1) · Lymphoma (1) · Melanoma (1) · Sarcoma, Ewing (1) · Sarcoma, Kaposi (1) · Sarcoma, Synovial (1)
DNA Virus Infections (2) · Infections (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Bone Tissue (2) · Neoplasms, Connective Tissue (2) · Neoplasms, Connective and Soft Tissue (2) · Virus Diseases (2) · Adenocarcinoma (1) · Bone Diseases (1) · Breast Diseases (1) · Carcinoma (1) · Carcinoma, Neuroendocrine (1) · Hemic and Lymphatic Diseases (1) · Herpesviridae Infections (1)
Radiation (1) · Radiotherapy (1) · flt3 ligand protein (1) · pembrolizumab (1) · poly ICLC (1) · tocilizumab (1)
Essen Biotech (1) · University of Southern California (1)
China (1) · United States (1)
Fumito Ito, MD (1)